![](https://www.investmentmonitor.ai/wp-content/uploads/sites/7/2021/09/shutterstock_1124862161.jpg)
CRScube Inc., a clinical trial software solutions company headquartered in South Korea, has announced the launch of its new office in London marking a significant step in its plan to grow worldwide.
Building on the company’s track record in Asia, the move highlights a commitment to introduce CRScube’s products to European and American markets.
CRScube’s offerings have been applied to more than 5,000 medical research projects worldwide in the last two decades. The company also provides a Data Capture (EDC) solution in Korea, and it has squarely established itself across the Asian market.
In an effort to enhance its standing on the international stage, CRScube has recently brought on board two experienced experts: Juan Munoz-Pujol, who serves as the chief strategy and development officer (CSDO), and Sylvain Berthelot, the vice president of strategy and marketing.
Stanley Kim, CRScube’s CEO, said “We are thrilled to expand our footprint into the UK. […] Our success in Asia has laid a strong foundation, and we are excited to bring our innovative solutions to sponsors and CROs in Europe and the US.”
Juan Munoz-Pujol, CSDO said “Our London office is a critical step in our international growth strategy. This expansion allows us to better serve our clients in Europe and the US, providing localized support while leveraging our global expertise.”
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
![](/wp-content/themes/goodlife-wp-B2B/assets/images/company-profile-unit.png)
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataWith offices in Japan, Korea, China, Europe and the United States, the company continues to grow and strives to be an industry leader in ensuring value to the clinical trials sector around the world.